Cargando…

Hepatitis B Viral DNA Among HBs Antigen Negative Healthy Blood Donors

BACKGROUND: Presence of occult hepatitis B infection (OBI) renders HBs antigen (HBsAg) undetectable by ELISA. Therefore it is valuable to evaluate the frequency of OBI among healthy blood donors to improve and perhaps change the strategies of blood screening to reduce the risk of HBV transmission. O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaezjalali, Maryam, Rashidpour, Shabnam, Rezaee, Hanieh, Hajibeigi, Bashir, Zeidi, Majid, Gachkar, Latif, Aghamohamad, Shadi, Najafi, Ronak, Goudarzi, Hossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651843/ https://www.ncbi.nlm.nih.gov/pubmed/23675384 http://dx.doi.org/10.5812/hepatmon.6590

Ejemplares similares

Prediction of conformational changes by single mutation in the hepatitis B virus surface antigen (HBsAg) identified in HBsAg-negative blood donors
por: Ie, Susan I, et al.
Publicado: (2010)

COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis
por: Dadashi, Masoud, et al.
Publicado: (2021)

Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors
por: Karimi, Gharib, et al.
Publicado: (2016)

AUSTRALIA ANTIGEN (HBsAG) IN INSTITUTIONALISED SCHIZOPHRENICS
por: Chaudhury, S., et al.
Publicado: (1993)

Detection of HBsAg mutants in the blood donor population of Pakistan
por: Farooq, Ahmad, et al.
Publicado: (2017)

Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients
por: Wang, Xian-ding, et al.
Publicado: (2021)

The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis
por: Babanejad, Mehran, et al.
Publicado: (2016)

DNA-mediated immunization of mice with plasmid encoding HBs antigen.
por: Yoon, S. J., et al.
Publicado: (1999)

HBV Genotyping in HBsAg-Positive Blood Donors from Southwestern Iran
por: Kohshour, Mojtaba Oraki, et al.
Publicado: (2010)

Formulation of HBs antigen in Montanide ISA266 shows superiority to commercial HBsAg vaccine in the induction of humoral immune responses
por: Savoji, Mohammad Ali, et al.
Publicado: (2019)

Seroprevalence of anti-HDV Ab and socioepidemiological characteristics among HBsAg-positive blood donors in Charmahal-o-Bakhtiyari province, Iran: Anti-HDV among HBsAg-positive blood donors
por: Tajbakhsh, Elahe, et al.
Publicado: (2011)

Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay
por: Seto, Wai-Kay, et al.
Publicado: (2012)

De novo hepatitis B surface antigen (HBsAg)-positive, core antibody (anti-HBc)-negative, hepatitis B virus infection post-liver transplant from an anti-HBc, HBsAg-negative donor
por: Bedi, Harjot K., et al.
Publicado: (2021)

In-hospital outcomes after primary percutaneous coronary intervention according to left ventricular ejection fraction
por: Vakili, Hossein, et al.
Publicado: (2014)

Performance Evaluation of an Improved HBsAg Assay (HBsAg NEXT) for the Detection of HBsAg Levels
por: Gupta, Ekta, et al.
Publicado: (2023)

Associates of poor physical and mental health-related quality of life in beta thalassemia-major/intermedia
por: Azarkeivan, Azita, et al.
Publicado: (2009)

Chemical Liver Function Tests and Epidemiologic Studies of HBsAg Positive Blood Donors
por: Kim, Yeong Chul, et al.
Publicado: (1986)

What are the causes and outcomes of the coexistence of HBsAg and anti-HBs?
por: Afyon, Murat
Publicado: (2016)

Vitamin D toxicity in a pediatric toxicological referral center; a cross-sectional study from Iran
por: Farnaghi, Fariba, et al.
Publicado: (2020)

Exposition of hepatitis B surface antigen (HBsAg) on the surface of HEK293T cell and evaluation of its expression
por: Mirian, Mina, et al.
Publicado: (2016)

Prevalence of HBc-Ab among HBs-Ag negative healthy blood donors in south of Iran
por: Khorami, Farhad, et al.
Publicado: (2013)

Efficacy and safety of stratified versus routine prophylaxis in living kidney transplantation from HBsAg+ donors to HBsAg− recipients: protocol for a multicentre, prospective, observational study
por: Wang, Xianding, et al.
Publicado: (2021)

Prevalence of hepatitis B surface antigen (HBsAg) in a blood donor population born prior to and after implementation of universal HBV vaccination in Shenzhen, China
por: Wang, Zhen, et al.
Publicado: (2016)

A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition In Vitro
por: Salpini, Romina, et al.
Publicado: (2020)

Analytical Performance of the Sysmex HISCL HBsAg Assay and Comparison with the Roche Elecsys HBsAg II Quant Assay in the Quantification of Hepatitis B Surface Antigen
por: Park, Joonhong, et al.
Publicado: (2021)

The Investigation of HBV Pre-S/S Gene Mutations in Occult HBV Infected Blood Donors with anti-HBs Positive
por: Guo, Yan, et al.
Publicado: (2022)

Hepatitis B Core IgM antibody (anti-HBcIgM) among hepatitis B Surface antigen (HBsAg) negative blood donors in Nigeria
por: Japhet, Margaret Oluwatoyin, et al.
Publicado: (2011)

Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C
por: Ryu, Ji Hyeong, et al.
Publicado: (2018)

Factors Associated With High Blood Lead Levels in a Sample of 100 Children in Tehran
por: Zamani, Nasim, et al.
Publicado: (2019)

Blood lead levels in pregnant women referring to midwifery clinic in a referral center in Tehran
por: Hassanian-Moghaddam, Hossein, et al.
Publicado: (2018)

Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination
por: Galati, Giovanni, et al.
Publicado: (2014)

Long-term outcomes of HBsAg/anti-HBs double-positive versus HBsAg single-positive patients with chronic hepatitis B
por: Kwak, Min-Sun, et al.
Publicado: (2019)

Decreased antigenicity profiles of immune-escaped and drug-resistant hepatitis B surface antigen (HBsAg) double mutants
por: Zhang, Mingshun, et al.
Publicado: (2013)

Fast antibody responses by immuno-targeting and nanotechnology strategies versus HBsAg vaccine
por: Rezaei, Mahsa, et al.
Publicado: (2021)

Diagnostic Yield of a Direct Quantitative Smear of Lower Respiratory Tract Secretions in Patients with Suspected Pneumonia Compared to a Semi-quantitative Culture
por: Shokouhi, Shervin, et al.
Publicado: (2017)

Prevalence of cytomegalovirus infection in patients with ulcerative colitis: a prospective cross-sectional study in Tehran, Iran
por: Yadegarynia, Davood, et al.
Publicado: (2018)

Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012–2013
por: Ansumana, Rashid, et al.
Publicado: (2018)

Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda
por: Makuza, Jean Damascene, et al.
Publicado: (2019)

Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs
por: Liu, Yong, et al.
Publicado: (2016)

Paradoxical HBsAg and anti-HBs coexistence among Chronic HBV Infections: Causes and Consequences
por: Jiang, Xinyi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nnb9hfh67nua9u16aqrkpim212